John T. Hunt
Oncology Drug Discovery
Bristol-Myers Squibb Research and Development
Princeton
NJ 08543-4000
USA
Name/email consistency: high
- Discovery of ixabepilone. Hunt, J.T. Mol. Cancer Ther. (2009)
- Discovery of the pyrrolo[2,1-f][1,2,4]triazine nucleus as a new kinase inhibitor template. Hunt, J.T., Mitt, T., Borzilleri, R., Gullo-Brown, J., Fargnoli, J., Fink, B., Han, W.C., Mortillo, S., Vite, G., Wautlet, B., Wong, T., Yu, C., Zheng, X., Bhide, R. J. Med. Chem. (2004)
- Discovery of (R)-7-cyano-2,3,4, 5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3- (phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine (BMS-214662), a farnesyltransferase inhibitor with potent preclinical antitumor activity. Hunt, J.T., Ding, C.Z., Batorsky, R., Bednarz, M., Bhide, R., Cho, Y., Chong, S., Chao, S., Gullo-Brown, J., Guo, P., Kim, S.H., Lee, F.Y., Leftheris, K., Miller, A., Mitt, T., Patel, M., Penhallow, B.A., Ricca, C., Rose, W.C., Schmidt, R., Slusarchyk, W.A., Vite, G., Manne, V. J. Med. Chem. (2000)